Antonio Benita
- Neu
- 32 Jahre der Erfahrung
- Mexiko, Mexiko-Stadt, Klinik von DR. IRERI ASTEINZA
Universität Istanbul Medizinische Fakultät Istanbul, Medizin, 02.07.2013
Universität Istanbul Medizinische Fakultät Istanbul, Herz-Kreislauf-Chirurgie, 20.12.2018
Medizinische Fakultät der Universität Istanbul: 2013-2019
Ausbildungs- und Forschungskrankenhaus Bagcilar: 2019-2021
Istanbuler Ausbildungsforschungskrankenhaus: 2021-2023
Biruni University Hospital: 2023-heute
Kongress der National Society of Vascular Surgery – Mündlicher Vortrag 2.2. Preis:
OZTAS DIDEM MELIS, Meric Mert, BEYAZ METIN ONUR, Onalan Mehmet Akif, Bahseliyev Siraslan, SONMEZ KIVILCIM, OTER KEREM, ZIYADE SEDAT, OMER BEYHAN, ALPAGUT IBRAHIM UFUK, UĞURLUCAN MURAT (2019). Untersuchung der Wirkung von Erythropoietin auf den Stammzellspiegel im Herz-Kreislauf-Gewebe bei diabetischen Ratten. 19. Nationaler Kongress für Gefäß- und endovaskuläre Chirurgie.
Ausbildung und Spezialisierung
Erfahrung
Education and Career
2019 – today
İstanbul Florence Nightingale Hospital
Cardiovascular Surgery
2017 - 2018
Bayrampaşa Kolan Hospital
Professor of Cardiovascular Surgery
2015 - 2017
GOP Medical Park
Cardiovascular Surgery
2013
University of Hannover-Freiburg
Cardiovascular Surgery
2012 - 2014
Koşuyolu Heart Training and Research Hospital
Heart Transplantation
2012
Toronto General Hospital
Cardiovascular Surgery
1996 - 2005
Uludağ University Faculty of Medicine
Cardiovascular Surgery Specialist, Associate Professor, Professor
1996 - 2015
Uludağ University Faculty of Medicine
Specialist, Assistant Professor, Associate Professor, Professor
1995 - 1996
GATA Haydarpaşa Training Hospital (Military Service)
1988 - 1994
Uludağ University Faculty of Medicine
Cardiovascular Surgery Residency
Wissarut Sakulpaptong, M.D., ist ein Board-zertifizierter Kardiologe und Mitglied des Kardiologie-Teams am King Chulalongkorn Memorial Hospital. Er ist auf fortgeschrittene Echokardiographie spezialisiert. Seine Arbeit umfasst transthorakale und transösophageale Untersuchungen, Strain-Analyse, 3D- und Stressechokardiographie sowie Bildgebung bei angeborenen Herzfehlern. Zudem hat er einen Master of Science (Medizin) der Chulalongkorn University.
Zu seinen Leitungsfunktionen zählen Chief Fellow (2024) und Chief Resident (2022). Zu seinen Auszeichnungen gehören der zweite Preis beim Echocardiography Annual Scientific Meeting 2025 (Heart Association of Thailand), die Ehrung als hervorragender Assistenzarzt im zweiten Ausbildungsjahr (2021) und als hervorragender Medizinabsolvent (2017). Er entwickelte einen Versorgungspfad für NSTEMI, ein Screening-Echokardiogramm-Projekt und eine Warfarin-Hausbesuchsklinik. Er präsentierte Forschung zur sepsisbedingten Myokarddysfunktion und trug zur thailändischen Migräne-Leitlinie 2022 bei.
Dr. Cagdas Erdogan ist Gastroenterologe am Ankara Etlik City Hospital. Er ist in Innerer Medizin und Gastroenterologie ausgebildet und erwarb seinen medizinischen Abschluss (MD) an der Dokuz Eylul University. Seine Facharztausbildung in Innerer Medizin absolvierte er 2014–2019; 2019–2022 folgte ein Gastroenterologie-Fellowship am Ankara City Hospital. Klinische Schwerpunkte sind erweiterte Endoskopie (ERCP, EUS, EMR, ESD, POEM, ÖGD/EGD, Koloskopie, Doppelballonenteroskopie), chronisch-entzündliche Darmerkrankungen und Hepatologie.
Er hat etwa 40 Publikationen. Seine Arbeiten erschienen u. a. in The Turkish Journal of Gastroenterology, Scientific Reports, Endoscopy und Digestive Diseases and Sciences. Hervorzuhebende Studien befassen sich mit Vedolizumab bei CED und der Prophylaxe der post-ERCP-Pankreatitis. Zudem berichtete er über eine 13-jährige Morbus-Crohn-Kohorte mit einem Vergleich von Infliximab und Adalimumab. Weitere Arbeiten betreffen Ergebnisse mit einem Adalimumab-Biosimilar sowie innovative endoskopische Therapien (MCA mittels Doppelballonenteroskopie, Holmiumlaser beim Bouveret-Syndrom, POEM beim Zenker-Divertikel und ESD bei ösophagealer Papillomatose).
Ahn Tae Hoon, MD, PhD, ist Kardiologe und Direktor des Herz-Kreislauf-Zentrums am Naeun Hospital. Er ist spezialisiert auf koronare Herzkrankheit (Angina pectoris, Myokardinfarkt), Hypertonie, Klappenerkrankungen, Herzinsuffizienz und interventionelle kardiovaskuläre Verfahren.
Er promovierte in Medizin an der Korea University College of Medicine. Seine Facharztausbildung in Innerer Medizin absolvierte er am Korea University Guro Hospital, das Kardiologie-Fellowship am Korea University Hyehwa Hospital. Zudem absolvierte er eine klinische Weiterbildung am Montreal Heart Institute.
Zuvor war er Professor und Direktor des Herz-Kreislauf-Zentrums am Gachon University Gil Medical Center. Er war Klinischer Professor am Korea University Anam Hospital und am Chung-Ang University Gwangmyeong Hospital. Zu seinen Leitungsfunktionen zählen Präsident der KSIC, KCCC, KVIS und KSC. Zudem war er Schatzmeister der KSC und Vorsitzender des Organisationskomitees von ENCORE SEOUL.
Professor Byung-Hee Oh, MD, PhD is a distinguished cardiologist with decades of clinical, academic, and leadership experience in the field of cardiovascular medicine. He is currently affiliated with Incheon Sejong Hospital, where he provides advanced care for patients with complex heart conditions. Professor Oh graduated from Seoul National University College of Medicine and completed his residency and fellowship training in Internal Medicine and Cardiology at Seoul National University Hospital, one of Korea’s most prestigious tertiary medical centers.
Throughout his career, Professor Oh has specialized in heart failure, coronary artery disease, hypertension, atrial fibrillation, and preventive cardiology. He has extensive experience in managing patients with chronic and advanced cardiovascular diseases, including post-myocardial infarction complications and complex arrhythmias. His clinical approach emphasizes evidence-based treatment, precise diagnostic evaluation, and long-term disease management tailored to each patient.
Professor Oh has held numerous leadership positions in both academic medicine and professional societies. He served as Professor of Cardiology at Seoul National University, as well as Director of the Cardiovascular Center and Head of the Division of Cardiology at major university hospitals. In addition, he has played a key role in shaping cardiovascular research and policy in Korea through his service as President of the Korean Society of Cardiology and leadership roles in national heart failure and hypertension organizations.
An internationally recognized scholar, Professor Oh has authored hundreds of peer-reviewed publications in leading domestic and international medical journals and has delivered invited lectures at major global cardiology conferences. His contributions to medicine and public health have been recognized with multiple prestigious awards, including national honors for medical excellence and leadership.
With his profound clinical expertise, academic achievements, and patient-centered philosophy, Professor Byung-Hee Oh is widely regarded as a trusted authority in adult cardiology, providing comprehensive and reliable care for patients seeking advanced cardiovascular treatment and prevention.
Dr. Kyung-Hee Kim, MD, PhD is a highly experienced cardiologist at Incheon Sejong Hospital, serving as the Director of the Heart Transplantation Center and Head of Cardiology. She earned her medical degree and postgraduate training, including both Master’s and Doctoral degrees, from Seoul National University College of Medicine. Dr. Kim completed advanced clinical training in cardiology and has pursued international fellowships, including research at the Mayo Clinic and other leading cardiovascular centers.
Dr. Kim is internationally recognized for her expertise in advanced heart failure, heart transplantation evaluation and management, mechanical circulatory support such as VAD (ventricular assist devices) and ECMO, as well as pulmonary hypertension and complex cardiomyopathies. She also specializes in care for patients with genetic heart disorders, valvular heart disease, and adult congenital heart disease, integrating cutting-edge diagnostics with personalized long-term treatment plans.
In her leadership roles at Incheon Sejong Hospital, Dr. Kim directs multidisciplinary care teams that collaborate across cardiac surgery, imaging, and intensive care to ensure optimal outcomes for patients with critical cardiac conditions. She has played a central role in shaping clinical protocols and educational programs, and her expertise has been recognized through prestigious awards and international appointments. Notably, Dr. Kim was appointed to the American Heart Association’s Clinical Cardiology Membership Committee, marking a significant international leadership role for a Korean cardiologist.
Dr. Kim is also an active contributor to cardiology research and guideline development. She has served as a committee leader in national and international professional societies and participates in development of clinical practice guidelines in pulmonary hypertension and heart failure. Her patient-centered approach emphasizes comprehensive evaluation, advanced therapeutics, and empathetic communication, making her a trusted specialist for patients with complex and high-risk cardiac conditions.
Dr. Min-Jeong Kim, MD, PhD is a highly experienced cardiologist at Incheon Sejong Hospital, specializing in interventional cardiology, heart failure management, hypertension, and preventive cardiology. She earned her medical degree and doctorate from Seoul National University College of Medicine, and completed her advanced clinical training in internal medicine and cardiovascular disease at one of Korea’s premier medical institutions.
Dr. Kim has extensive experience in the diagnosis and treatment of a wide range of cardiovascular conditions, including coronary artery disease, chronic heart failure, arrhythmia, and hypertension. She is skilled in performing coronary angiography, percutaneous coronary interventions, diagnostic echocardiography, and comprehensive cardiovascular evaluations. Her clinical practice emphasizes evidence-based care, precise risk stratification, and personalized treatment planning tailored to each patient’s needs.
Throughout her career, Dr. Kim has been actively involved in multidisciplinary cardiac care teams that integrate cardiology, imaging, and interventional services to achieve optimal patient outcomes. She is committed to advancing clinical excellence in preventive cardiology and long-term heart disease management, helping patients reduce cardiovascular risk factors and improve quality of life.
Dr. Kim is known for her patient-centered approach, clear communication, and compassionate care. She places strong emphasis on helping patients understand their conditions, treatment options, and preventive strategies. Her contributions to clinical practice, education, and patient advocacy have made her a trusted cardiology specialist for both domestic and international patients seeking advanced heart care.